Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from the United Kingdom

被引：19

作者：

Karampampa, Korinna ^{[1
]}

Gustavsson, Anders ^{[1
,2
]}

Miltenburger, Carolin

Tyas, David

机构：

[1] Karolinska Inst, Inst Environm Med, Div Epidemiol, S-17177 Stockholm, Sweden

[2] Karolinska Inst, Alzheimer Dis Res Ctr, S-17177 Stockholm, Sweden

来源：

MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷

关键词：

QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; COSTS; UK; SEVERITY;

D O I：

10.1177/1352458512441566e

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：41 / 45

页数：5

共 16 条

[1]

[Anonymous], 2011, OECD NET INC TAX NAT

[2]

[Anonymous], COST EFF PROV DIS MO

[3]

British National Formulary, 2011, PRIC MED REQ PRESCR

[4] Multiple sclerosis [J].

Compston, Alastair ;

Coles, Alasdair .

LANCET, 2008, 372 (9648) :1502-1517

[5]

Davison A.C., 2006, BOOTSTRAP METHODS TH

[6]

EUROSTAT, 2011, HARM IND CONS PRIC

[7] Costs, quality of life and disease severity in multiple sclerosis:: a cross-sectional study in Sweden [J].

Henriksson, F ;

Fredrikson, S ;

Masterman, T ;

Jönsson, B .

EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (01) :27-35

[8]

Kobelt G., 2009, ACCESS INNOVATIVE TR

[9]

Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS96

[10] The Wilcoxon-Mann-Whitney test condemned [J].

Ludbrook, J .

BRITISH JOURNAL OF SURGERY, 1996, 83 (01) :136-137

← 1 2 →